[96a5a0]: / output / allTrials / identified / NCT00204776_identified.json

Download this file

155 lines (155 with data), 5.4 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
{
"info": {
"nct_id": "NCT00204776",
"official_title": "A Phase II Trial of Capecitabine and Oxaliplatin in Metastatic Breast Cancer",
"inclusion_criteria": "* preserved organ function\n* good performance status\n* no more than one prior therapy\n* no active brain metastasis\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* No prior capecitabine or oxaliplatin\n* no con-current therapy",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* preserved organ function",
"criterions": [
{
"exact_snippets": "preserved organ function",
"criterion": "organ function",
"requirements": [
{
"requirement_type": "condition",
"expected_value": "preserved"
}
]
}
]
},
{
"line": "* good performance status",
"criterions": [
{
"exact_snippets": "good performance status",
"criterion": "performance status",
"requirements": [
{
"requirement_type": "quality",
"expected_value": "good"
}
]
}
]
},
{
"line": "* no more than one prior therapy",
"criterions": [
{
"exact_snippets": "no more than one prior therapy",
"criterion": "prior therapy",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<=",
"value": 1,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* no active brain metastasis",
"criterions": [
{
"exact_snippets": "no active brain metastasis",
"criterion": "brain metastasis",
"requirements": [
{
"requirement_type": "activity",
"expected_value": false
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* No prior capecitabine or oxaliplatin",
"criterions": [
{
"exact_snippets": "No prior capecitabine",
"criterion": "prior capecitabine",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No prior ... oxaliplatin",
"criterion": "prior oxaliplatin",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* no con-current therapy",
"criterions": [
{
"exact_snippets": "no con-current therapy",
"criterion": "con-current therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}